Analysts Offer Insights on Healthcare Companies: Jounce Therapeutics Inc (NSTG) and NanoString Tech (NSTG)


There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Jounce Therapeutics Inc (NASDAQ: JNCE) and NanoString Tech (NASDAQ: NSTG) with bullish sentiments.

Jounce Therapeutics Inc (NASDAQ: JNCE)

In a report released today, Michael Ulz from Robert W. Baird maintained a Buy rating on Jounce Therapeutics Inc (NASDAQ: JNCE), with a price target of $20. The company’s shares closed on Friday at $11.23, close to its 52-week low of $10.21.

According to TipRanks.com, Ulz is a 3-star analyst with an average return of 6.1% and a 59.1% success rate. Ulz covers the Healthcare sector, focusing on stocks such as Merrimack Pharmaceuticals, Mersana Therapeutics Inc, and Alexion Pharmaceuticals.

Jounce Therapeutics Inc has an analyst consensus of Moderate Buy, with a price target consensus of $16.

See today’s analyst top recommended stocks >>

NanoString Tech (NASDAQ: NSTG)

In a report released today, Catherine Schulte from Robert W. Baird maintained a Buy rating on NanoString Tech (NASDAQ: NSTG), with a price target of $15. The company’s shares closed on Friday at $12.91.

According to TipRanks.com, Schulte is a 5-star analyst with an average return of 24.4% and a 78.5% success rate. Schulte covers the Healthcare sector, focusing on stocks such as PerkinElmer, Waters Corp, and Illumina.

NanoString Tech has an analyst consensus of Moderate Buy, with a price target consensus of $15.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts